No Data
Jinxin Reproductive (01951) repurchased 6.3 million shares on May 28 at a cost of HK$13.5784 million.
Jinxin Reproductive (01951) announced that on May 28, 2026, the company repurchased 6.3 million shares at a total cost of HK$13.5784 million, with the repurchase price per share ranging from HK$2.13 to HK$2.17.
Jinxin Fertility (01951) repurchased 1.304 million shares on May 27 at a cost of approximately HK$2.8387 million.
Jinxin Fertility (01951) announced that on May 27, 2026, it repurchased 1.304 million shares at a cost of approximately HK$2.8387 million.
Hong Kong Stock Ratings Summary: Guosen Securities maintains its 'Outperform Market' rating on Bilibili.
Cailian Press will regularly compile ratings and target prices from various institutions for Hong Kong stocks.
Jinxin Reproductive (01951) repurchased 1.87 million shares on May 22 at a cost of HK$4.2101 million.
Jinxin Fertility (01951) announced that on May 22, 2026, the company repurchased 1.87 million shares at a cost of HK$4.2101 million.
Jinxin Reproductive (01951) repurchased 1.293 million shares on May 21 at a cost of HK$2.959 million.
Jinxin Fertility (01951) announced that on May 21, 2026, it repurchased 1.293 million shares at a cost of HK$2.959 million.
Jinxin Fertility (01951) repurchased 1.1395 million shares on May 19 at a cost of HK$2.669 million.
Jinxin Fertility (01951) announced that on May 19, 2026, it repurchased 1,139,500 shares at a cost of HK$2.669 million.